In vivo effects of antiviral acyclic nucleoside phosphonate 9-[2-(phosphonomethoxy)ethyl]adenine (adefovir) on cytochrome P450 system of rat liver microsomes

J Biomed Sci. 2006 May;13(3):295-301. doi: 10.1007/s11373-005-9067-1. Epub 2006 Jan 14.

Abstract

Interference of antiviral agent adefovir, i.e. 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with microsomal drug metabolizing system was investigated in rats. The content of total liver cytochrome P450 (CYP) was lowered while that of its denaturated form, P420, was elevated in animals intraperitoneally treated with PMEA (25 mg/kg). Similar effect was observed after treatment with a prodrug of adevofir, adefovir dipivoxil (bisPOM-PMEA). The CYP2E1-dependent formation of 4-nitrocatechol from p-nitrophenol was diminished, though the specific activity of p-nitrophenol hydroxylase remained unchanged. PMEA had no influence on expression of CYP2E1 protein and mRNA and mRNAs of other P450 isoenzymes (1A1, 1A2, 2C11, 3A1, 3A2, and 4A1). It may be concluded that repeated systemic administration of higher doses of PMEA results in a partial degradation of rat CYP protein to inactive P420.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / chemistry
  • Adenine / pharmacology
  • Animals
  • Antiviral Agents / pharmacology*
  • Catechols / pharmacology
  • Cytochrome P-450 Enzyme System / chemistry*
  • Female
  • Microsomes, Liver / drug effects*
  • Nitrophenols / chemistry
  • Organophosphonates / chemistry
  • Organophosphonates / pharmacology*
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Inbred Lew

Substances

  • Antiviral Agents
  • Catechols
  • Nitrophenols
  • Organophosphonates
  • RNA, Messenger
  • adefovir
  • Cytochrome P-450 Enzyme System
  • Adenine
  • 4-nitrocatechol
  • 4-nitrophenol